Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tower Semiconductor Announces First Quarter 2024 Financial Results and Conference Call
-
Municipality Finance issues a GBP 25 million tap under its MTN programme
-
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair
-
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology
-
JuneX Capital Partners Launch “Founders Office“ with €100M Evergreen Fund to Back European Entrepreneurs in Human Capital and Investment Management
-
FORVIA TO OFFER AN ADDITIONAL €200 MILLION OF 5.500% SENIOR NOTES DUE 2031 AIMING TO PARTIALLY REFINANCE ITS 7.250% 2026 BONDS
-
Scatec signs PPA with Statkraft for new 142 MW solar plant in Brazil
-
Siili Solutions Plc: Business review, 1 January–31 March 2024
-
Enlight Research analysed INVL Technology’s financial results for 2023
-
Form 8.5 (EPT/RI) - Renalytix plc
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Futu Announces the Number of Its Clients in Malaysia Has Surpassed 100,000
-
News from INVL Technology managed companies: NRD Cyber Security's growth shows an increasing demand for quality cybersecurity services
-
Groupe Casino: The New Casino embarks on its transformation plan
-
Stolt-Nielsen Limited shares trade ex-dividend
-
Heineken Holding N.V. reports on 2024 first-quarter trading
-
Cornish Metals Launches New Interactive Investor Hub
-
AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting
-
NBPE Announces Audited 2023 Results and 31 March 2024 Est. NAV
-
Pharming Group to report first quarter 2024 financial results on May 8
-
Heineken N.V. reports on 2024 first-quarter trading
-
Transaction in own shares
-
Michelin : Disclosure of trading in own shares - April 24th 2024
-
EXEL Industries : Second quarter 2023–2024 sales: up 1.8%
-
Vistin Pharma ASA: First quarter 2024 financial results
-
DSV, 1104 - LAUNCH OF NEW SHARE BUYBACK PROGRAMME ACCORDING TO THE SAFE HARBOUR METHOD
-
DSV, 1103 - INTERIM FINANCIAL REPORT Q1 2024
-
Press Release Orange: Good start to the year, strong momentum on “Lead the Future”
-
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent
-
Ringkjøbing Landbobank’s quarterly report for the first quarter of 2024
-
Transaction in Own Shares
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Q1 2024 results: KPN delivers solid start to the year
-
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent
-
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
-
NaaS Technology and its Parent Company, NewLink, Join the Open Invention Network Community
-
Norsk Hydro: Resilient in weak markets, positioned for growth
-
Start of Day Message
-
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
-
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023
-
TGS Q1 2024 Presentation and Webcast
-
First quarter 2024 financial information: Good start to the year
-
Melexis Q1 2024 results – First quarter sales of 241.8 million EUR
-
Wereldhave Trading update Q1 2024
-
Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates
-
Reminder: Unifiedpost Group Strategy Update Presentation on 30 April 2024
-
Vopak reports strong Q1 2024 results and increases FY 2024 outlook
-
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
